MDB — Medicofarma Biotech SA Balance Sheet
0.000.00%
- PLN17.81m
- PLN17.81m
- PLN1.22m
Annual balance sheet for Medicofarma Biotech SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | PAS | PAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.064 | 0.077 | 0.508 | 0.005 | 0.006 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.149 | 1.44 | 0.583 | 0.38 | 0.632 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.387 | 2.08 | 2.26 | 2.52 | 3.81 |
Net Property, Plant And Equipment | 0 | 12.7 | 12.6 | 12.1 | 10.6 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.396 | 16.8 | 16.4 | 15 | 14.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.625 | 0.522 | 3.28 | 4.02 | 4.49 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.625 | 2.56 | 3.76 | 5.8 | 7.84 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.229 | 14.2 | 12.6 | 9.18 | 6.87 |
Total Liabilities & Shareholders' Equity | 0.396 | 16.8 | 16.4 | 15 | 14.7 |
Total Common Shares Outstanding |